Where does Biotec Pharmacon Asa rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biotec Pharmacon Asa ranks #25,885 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biotec Pharmacon Asa hold?

Biotec Pharmacon Asa holds 10 US utility patents granted between 2015 and 2020, spanning 9 technology areas.

What is Biotec Pharmacon Asa's Innovation Score?

Biotec Pharmacon Asa has an Innovation Score of 30.3 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biotec Pharmacon Asa focus on?

Biotec Pharmacon Asa's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 7 patents, ranking #2,588 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Biotec Pharmacon Asa's patent grant rate increasing or decreasing?

Biotec Pharmacon Asa's recent grant velocity is -89% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biotec Pharmacon Asa's patents?

Biotec Pharmacon Asa's patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biotec Pharmacon Asa patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biotec Pharmacon Asa

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biotec ranks #25,885 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#25,885
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.3/100): 19.0
avg claims per patent: -89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25885 · Foreign Corporation #25,885 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,885/49,997
PHOTO-FINISH Biocept
CPC-NARROW A61P · 9 areas
INNOV-THIN 30.3/100
CLAIMS-RICH 19.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -89% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Biocept, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biotec’s 30.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (27%) Velocity 0.0 pts (0%) Breadth 10.6 pts (35%) Claim depth 11.4 pts (38%)

Qualcomm Incorporated · highest

85
Biotec Pharmacon Asa · this assignee

30
3D Lighting… · lowest

7

What this shows Biotec's Innovation Score is 30.3/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Biotec?

Each dot is one of Biotec’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biotec’s own 19.0 claims/patent is ABOVE the 17.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biotec vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biotec's grants concentrate

Biotec Pharmacon Asa is a focused PatentsView assignee: 9 CPC subclasses with 70% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2018. By volume, Biotec sits between BioSystems Consulting, Inc. and Black Knight IP Holding Company, LLC.

Biosystems Consul…

10
Biocept

10
Biogen

10
Biomerica

10
Biotronik CRM Pat…

10
Bitro Group

10
Black Gold Pump a…

10
Black Knight IP H…

10
Biotec Pharmacon… ◀

10

What this shows Biotec holds 10 patents at rank #25,909, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biotec

By rank, the assignees closest to #25,909 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biotec's primary technology class.

Biotec's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biotec Pharmacon Asa patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	30.0%
2016	2	20.0%
2017	3	30.0%
2018	1	10.0%
2020	1	10.0%

Which technologies does Biotec Pharmacon Asa patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C08B - POLYSACCHARIDES; Derivatives Thereof 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 3

C12Y - Enzymes 2

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08L - Compositions OF Macromolecular Compounds 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Biotec Pharmacon Asa's patent record in context - here's where to go next.

Biotec Pharmacon Asa's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #25,885 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biotec Pharmacon Asa against BioSystems Consulting, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.